0
Menu
Logo Effik

Effik

On Soin et Nature, discover Effik, a brand specializing in women’s and men’s health care, offering tailored solutions to improve intimate well-being, fertility, and digestive health. Formulated with high-quality ingredients, Effik products are designed to meet the specific needs of each individual while ensuring effectiveness and safety.

More details
Filter
Number of products : 18
Sort
Sort
Close
Lomexin 2% Cream for Skin Fungal Infections, 30 g Lomexin 2% Cream for Skin Fungal Infections, 30 g
€6.89
Shipped within 24h
Geliofil Protect Vaginal Gel, 7 Doses, 5 ml Geliofil Protect Vaginal Gel, 7 Doses, 5 ml
€13.99
Shipped within 24h
Lomexin 2% Cream for Fungal Infections, 15 g Tube Lomexin 2% Cream for Fungal Infections, 15 g Tube
€2.99
Add to cart
Shipped within 24h
Zelesse Intimate Hygiene Soap 250 ml Zelesse Intimate Hygiene Soap 250 ml
€5.90
Shipped within 24h
Lomexin 600 mg, 2 Vaginal Capsules for Candidiasis Lomexin 600 mg, 2 Vaginal Capsules for Candidiasis
€9.86
Add to cart
Shipped within 24h
Monazol 2% Cream for Vulvar Yeast Infection, 15 g Monazol 2% Cream for Vulvar Yeast Infection, 15 g
€3.99
Shipped within 24h
Ainara Moisturizing Intimate Lubricant 30 g Ainara Moisturizing Intimate Lubricant 30 g
€14.35
Shipped within 24h
Ovunol Women's Fertility, 30 packets Ovunol Women's Fertility, 30 packets
€28.90
Shipped within 24h
Lomexin 600 mg Vaginal Capsule for Yeast Infection Lomexin 600 mg Vaginal Capsule for Yeast Infection
€4.36
Add to cart
Shipped within 24h
Natalben Mama (Gynefam) Lactation 60 capsules Natalben Mama (Gynefam) Lactation 60 capsules
€20.20
Shipped within 24h
Polybactum Vaginal Suppositories, 3 Suppositories Polybactum Vaginal Suppositories, 3 Suppositories
€15.95
Shipped within 24h
Andromas Fertility Powder 30 sachets Andromas Fertility Powder 30 sachets
€43.19
Shipped within 24h
Fertifol Folic Acid 400 µg, 90 tablets Fertifol Folic Acid 400 µg, 90 tablets
€9.65
Shipped within 24h
Natalben Pregnancy Oro (Gynéfam) 28 sachets Natalben Pregnancy Oro (Gynéfam) 28 sachets
€22.85
Shipped within 24h

EFFIK: A pharmaceutical company at the heart of women’s health for three decades

Founded in 1992, the French pharmaceutical laboratory EFFIK has dedicated its 30 years of existence to offering medical solutions tailored to women’s needs at every stage of their lives. From the very beginning, the company’s goal has been clear: to improve patient care by developing innovative, safe gynecological products that meet the pharmaceutical industry’s strictest standards.

EFFIK is much more than just a company; it is a trusted partner for healthcare professionals. Thanks to its manageable size and highly specialized teams in Research and Development (R&D) and Quality Assurance, the company has established itself as a key player in women’s health in France and Europe. With solutions tailored to issues such as contraception, menopause, and supplementation during pregnancy, EFFIK meets the specific needs of millions of women, day after day.

A Major Player in Gynecology for Over 30 Years

Since its founding, EFFIK has evolved to become an undisputed leader in gynecology, a vital yet often underrepresented field. This position is built on close and ongoing collaboration with gynecologists, midwives, pharmacists, and other healthcare professionals. Thanks to these partnerships, EFFIK develops products that meet high standards, both in terms of performance and safety.

Women’s health evolves over time, and EFFIK is fully aware of this. Whether supporting women in their contraceptive journey, their desire to become pregnant, or the challenges associated with menopause, the company has innovated and adapted to the changing needs of its patients. Each product is designed to provide a targeted solution while improving the quality of daily life.

At EFFIK, innovation and excellence are not merely goals: they are core values that guide every decision. The company is dedicated to addressing medical and human challenges while remaining committed to impeccable ethics. Since its inception, EFFIK has been committed to responsible business practices, complying with regulations and adopting a sustainable development approach.

Furthermore, EFFIK places great value onactively listening to the needs of women and healthcare professionals. This collaborative approach enables the creation of solutions that are perfectly aligned with patients’ expectations, while ensuring the continuous improvement of existing products. By choosing EFFIK, women benefit not only from cutting-edge medical expertise but also from sincere and compassionate support.

Strategic Diversification: Neurology and Rare Diseases

In 2016, the company took a significant step forward by expanding its scope to include neurology and rare diseases. This expansion marks a new chapter in EFFIK’s history, as the company is now committed to helping patients suffering from complex conditions such as Amyotrophic Lateral Sclerosis (ALS) and Duchenne muscular dystrophy. Although rare, these diseases have a major impact on the quality of life of patients and their families, and EFFIK is doing everything in its power to develop innovative and accessible treatments.

The company has assembled a specialized team dedicated to these conditions and works closely with patient organizations and healthcare professionals to provide tangible support at every stage of the care journey. Thanks to its advances in R&D, EFFIK continues to push the boundaries of medicine in these fields, while remaining true to its original mission: to improve patients’ lives, regardless of their condition.

EFFIK’s commitment extends beyond pharmaceutical research. The company actively collaborates with recognized organizations, such asARSLA (Association for Research on Amyotrophic Lateral Sclerosis) andthe National Spina Bifida Association. These partnerships aim to raise awareness among patients and improve the prevention of serious diseases, while supporting affected families.

Through concrete actions, such as educational programs and community outreach initiatives (for example, the Race of Heroes), EFFIK demonstrates its deep commitment to the communities it serves. These efforts reflect a simple yet powerful philosophy: every action taken by the laboratory is focused on the well-being of patients and their loved ones.

At the heart of its mission, EFFIK remains firmly focused on the future. The laboratory continues to develop innovative solutions while strengthening its commitments to transparency, sustainability, andethics. As a responsible corporate citizen, EFFIK aspires to become a global leader in the fields of gynecology and rare diseases, drawing on strong values and recognized expertise.

With such a commitment to innovation and health, EFFIK is much more than just a supplier of pharmaceutical products. It is a trusted partner, determined to improve the lives of women and patients around the world.

EFFIK’s Product Lines: A Solution for Every Need

EFFIK offers a comprehensive range of products designed to meet the diverse needs of patients and healthcare professionals. Each solution is the result of in-depth research, ensuring efficacy and safety.

  • Contraception: A diverse selection to allow every woman to choose the method that suits her best, in line with her lifestyle and preferences.
  • Fertility: Specific treatments to support women in their journey to parenthood by optimizing their chances of conception.
  • Preconception, Pregnancy & Breastfeeding: Supplements and solutions to ensure optimal health for both mother and child during these critical periods.
  • Menopause: Products designed to alleviate symptoms associated with menopause, such as hot flashes, and to improve daily comfort.
  • Infectious Diseases: A line dedicated to the prevention and treatment of gynecological infections, to maintain intimate health.
  • Intimate Comfort: Solutions tailored to women’s specific needs, promoting lasting well-being.
  • Various Therapeutic Products: Complementary treatments to address a variety of issues outside the field of gynecology.
  • Amyotrophic Lateral Sclerosis (ALS): Innovative therapies to improve the management of this neurodegenerative disease.
  • Duchenne muscular dystrophy: Solutions developed to meet the needs of patients and their families facing this rare condition.